Renaissance Technologies’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,180
| Closed | -$10K | – | 4298 |
|
|
2023
Q2 | $10K | Buy |
15,180
+855
| +6% | +$563 | ﹤0.01% | 3830 |
|
|
2023
Q1 | $20K | Sell |
14,325
-58,843
| -80% | -$82.2K | ﹤0.01% | 3825 |
|
|
2022
Q4 | $92K | Sell |
73,168
-9,942
| -12% | -$12.5K | ﹤0.01% | 3649 |
|
|
2022
Q3 | $357K | Buy |
83,110
+59,645
| +254% | +$256K | ﹤0.01% | 3117 |
|
|
2022
Q2 | $122K | Sell |
23,465
-88,890
| -79% | -$462K | ﹤0.01% | 3798 |
|
|
2022
Q1 | $1.35M | Buy |
+112,355
| New | +$1.35M | ﹤0.01% | 2525 |
|
|
2021
Q3 | – | Sell |
-65,251
| Closed | -$1.44M | – | 3966 |
|
|
2021
Q2 | $1.44M | Buy |
+65,251
| New | +$1.44M | ﹤0.01% | 2468 |
|
|
2021
Q1 | – | Sell |
-31,499
| Closed | -$541K | – | 3827 |
|
|
2020
Q4 | $541K | Buy |
31,499
+14,612
| +87% | +$251K | ﹤0.01% | 2793 |
|
|
2020
Q3 | $275K | Buy |
16,887
+10,447
| +162% | +$170K | ﹤0.01% | 3027 |
|
|
2020
Q2 | $74K | Sell |
6,440
-4,830
| -43% | -$55.5K | ﹤0.01% | 3305 |
|
|
2020
Q1 | $113K | Buy |
11,270
+7,765
| +222% | +$77.9K | ﹤0.01% | 3206 |
|
|
2019
Q4 | $39K | Buy |
+3,505
| New | +$39K | ﹤0.01% | 3413 |
|